Impact BioMedical Inc./$IBO
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Impact BioMedical Inc.
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Ticker
$IBO
Sector
Primary listing
AMEX
Employees
2
Headquarters
Website
IBO Metrics
BasicAdvanced
$62m
-
-$0.23
-
-
Price and volume
Market cap
$62m
52-week high
$1.95
52-week low
$0.36
Average daily volume
62k
Financial strength
Current ratio
0.223
Quick ratio
0.012
Interest coverage (TTM)
-10.63%
Profitability
EBITDA (TTM)
-4.12
Gross margin (TTM)
-987.18%
Net profit margin (TTM)
-32,969.23%
Operating margin (TTM)
-14,228.21%
Effective tax rate (TTM)
16.69%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on assets (TTM)
-18.68%
Return on equity (TTM)
-119.66%
Valuation
Price to revenue (TTM)
821.937
Price to book
5.43
Price to tangible book (TTM)
-11.86
Price to free cash flow (TTM)
-19.147
Free cash flow yield (TTM)
-5.22%
Free cash flow per share (TTM)
-0.03
Growth
Earnings per share change (TTM)
-89.58%
3-year revenue growth (CAGR)
-7.95%
3-year earnings per share growth (CAGR)
32.11%
IBO News
AllArticlesVideos
Impact Biomedical Investor News: Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO
Business Wire·2 months ago
Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs